Myrbetriq
Urinary Incontinence in Women on MedicineNet »
"Urinary incontinence (UI) in women facts
*Urinary incontinence (UI) in men facts Medically Edited by: Melissa Conrad Stöppler, MD
- The definition of urinary incontinence in women is the unintentional loss of urine."...
Read the entire article on MedicineNet »
© 1999-2013 MedicineNet, Inc All right reserved
Myrbetriq
MYRBETRIQ™
(mirabegron) Extended Release Tablets
DRUG DESCRIPTION
Mirabegron is a beta-3 adrenergic agonist. The chemical name is 2-(2-aminothiazol-4-yl)-N-[4-(2-{[(2R)-2-hydroxy- 2-phenylethyl]amino}ethyl)phenyl]acetamide having an empirical formula of C21H24N4O2S and a molecular weight of 396.51. The structural formula of mirabegron is:
 |
Mirabegron is a white powder. It is practically insoluble in water (0.082 mg/mL). It is soluble in methanol and dimethyl sulfoxide.
Each Myrbetriq extended release tablet, for oral administration contains either 25 mg or 50 mg of mirabegron and the following inactive ingredients: polyethylene oxide, polyethylene glycol, hydroxypropyl cellulose, butylated hydroxytoluene, magnesium stearate, hypromellose, yellow ferric oxide, and red ferric oxide (25 mg tablet only).
Last reviewed on RxList: 3/25/2013
This monograph has been modified to include the generic and brand name in many instances.
Additional Myrbetriq Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
